Zealand Pharma A/S American Depositary Shares
ZEAL
ZEAL was delisted on the 29th of September, 2022.
12 hedge funds and large institutions have $16.8M invested in Zealand Pharma A/S American Depositary Shares in 2021 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 3 closing their positions.
14% less funds holding
Funds holding: 14 → 12 (-2)
23% less capital invested
Capital invested by funds: $22M → $16.8M (-$5.14M)
25% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 4
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$367K |
| 2 |
Morgan Stanley
New York
|
+$79.6K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$20.7K |
| 4 |
SWM
Spire Wealth Management
Mclean,
Virginia
|
+$7.63K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$59.8K |
| 2 |
JCM
Jacobi Capital Management
Pittston,
Pennsylvania
|
-$28K |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$15.8K |
| 4 |
S
SignatureFD
Atlanta,
Georgia
|
-$5K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$4.78K |
ZEAL Hedge Fund Activity: Q4 2021 in Review
12 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in Zealand Pharma A/S American Depositary Shares (ZEAL) for Q4 2021, worth a combined $16.8M — down 23% from $22M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of ZEAL and 1 opened new positions — a net loss of 2 holders — while 4 trimmed existing stakes and 3 added.
The largest buyer was Jane Street, adding an estimated $367K. The largest seller was BlackRock, cutting an estimated $59.8K.
- 12 institutional investors held Zealand Pharma A/S American Depositary Shares (ZEAL) as of Q4 2021, down from 14 in Q3 2021.
- Funds reported $16.8M of Zealand Pharma A/S American Depositary Shares stock for Q4 2021, down 23% quarter-over-quarter.
- 1 fund opened new Zealand Pharma A/S American Depositary Shares positions in Q4 2021 and 3 closed out, a net change of -2 holders.
- The largest Zealand Pharma A/S American Depositary Shares buyer in Q4 2021 was Jane Street, an estimated $367K added.
- The largest Zealand Pharma A/S American Depositary Shares seller in Q4 2021 was BlackRock, an estimated $59.8K sold.
Based on aggregated 13F filings for Q4 2021.